Trump Taps Palantir to Compile Data on Americans
By Sheera Frenkel and Aaron Krolik,
The New York Times
| 05. 30. 2025
In March, President Trump signed an executive order calling for the federal government to share data across agencies, raising questions over whether he might compile a master list of personal information on Americans that could give him untold surveillance power.
Mr. Trump has not publicly talked about the effort since. But behind the scenes, officials have quietly put technological building blocks into place to enable his plan. In particular, they have turned to one company: Palantir, the data analysis and technology firm.
The Trump administration has expanded Palantir’s work across the federal government in recent months. The company has received more than $113 million in federal government spending since Mr. Trump took office, according to public records, including additional funds from existing contracts as well as new contracts with the Department of Homeland Security and the Pentagon. (This does not include a $795 million contract that the Department of Defense awarded the company last week, which has not been spent.)
Representatives of Palantir are also speaking to at least two other agencies — the Social Security Administration and the...
Related Articles
By Megan Mineiro and Caroline Kitchener, The New York Times | 10.05.2025
Kathleen Whipple and her husband had dreamed of a big family, but struggled to conceive.
Upon his return from an overseas deployment with the Navy, the couple learned from a fertility doctor that her husband’s sperm count was half of...
By Karin Hammarberg, Alex Polyakov, Catherine Mills, and Karinne Ludlow, The Conversation | 10.03.2025
Reports of several cases of embryo and sperm mix-ups have put the Australian fertility industry in the spotlight for all the wrong reasons.
These bungles have raised serious questions about the industry’s current model of self-regulation, and demonstrate a lack...
By Karin Hammarberg and Catherine Mills, BioNews | 10.13.2025
The Australian fertility industry has been rocked by several recent cases of embryo and sperm mix-ups. With a lack of transparency about what clinics do to prevent such errors recurring, trust and confidence in the industry and how it is...
By Katherine Bourzac, Nature | 09.25.2025
A judge in New York rejected a request on 23 September to disqualify the use of cutting-edge DNA sequencing as evidence in a case against an alleged serial killer. The ruling paves the way for a type of DNA analysis...